Nicotine acts as a pharmacological chaperone to up-regulate human α4β2 acetylcholine receptors

Molecular Pharmacology

Volumn 68, Issue 6, 2005, Pages 1839-1851

  Kuryatov, A ^a   Luo, J ^a   Cooper, J ^a   Lindstrom, J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; CHOLINERGIC RECEPTOR; MECAMYLAMINE; NICOTINE; NICOTINIC RECEPTOR;

ARTICLE; CONFORMATION; ENDOPLASMIC RETICULUM; HUMAN; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

CELL LINE; CROSS-LINKING REAGENTS; DIMERIZATION; EPILEPSY, FRONTAL LOBE; HUMANS; MOLECULAR CHAPERONES; MUTATION; NICOTINE; OCTOXYNOL; PROTEIN SUBUNITS; RECEPTORS, NICOTINIC; TRANSFECTION; UP-REGULATION;

EID: 27844472836     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.105.012419     Document Type: Article

References (41)

1. Benowitz N (1996) Pharmacology of nicotine: addiction and therapeutics. Ann Rev Pharmacol Toxicol 36:597-613.
2. Buisson B, Gopalakrishnan M, Arneric SP, Sullivan JP, and Daniel D (1996) Human α4β2 neuronal nicotinic acetylcholine receptor in HEK 293 cells: a patch-clamp study. J Neurosci 16:7880-7891.
3. Collins A and Marks M (1996) Are nicotinic receptors activated or inhibited following chronic nicotine treatment? Drug Dev Res 38:231-242.
4. Conroy WG, Saedi MS, and Lindstrom J (1990) TE671 cells express an abundance of a partially mature acetylcholine receptor α subunit which has characteristics of an assembly intermediate. J Biol Chem 265:21642-21651.
5. Cooper S, Harkness P, Baker E, and Millar N (1999) Upregulation of cell surface α4β2 neuronal nicotinic receptors by lower temperature and expression of chimeric subunits. J Biol Chem 274:27145-27152.
6. Darsow T, Booker TK, Pina-Crespo JC, and Heinemann SF (2005) Exocytic trafficking is required for nicotine-induced upregulation of α4β2 nicotinic acetylcholine receptors. J Biol Chem 280:18311-18320.
7. Fenster CP, Beckman ML, Parker JC, Sheffield EB, Whitworth TL, Quick MW, and Lester RA (1999) Regulation of α4β2 nicotinic receptor desensitization by calcium and protein kinase C. Mol Pharmacol 55:432-443.
8. Figl A, Viseshakul N, Shafaee N, Forsayeth J, and Cohen BN (1998) Two mutations linked to nocturnal frontal lobe epilepsy cause use-dependent potentiation of the nicotinic ACh response. J Physiol (Lond) 513:655-670.
9. Fitch RW, Xiao Y, Kellar KJ, and Daly JW (2003) Membrane potential fluorescence: a rapid and highly sensitive assay for nicotinic receptor channel function. Proc Natl Acad Sci USA 100:4909-4914.
10. Flores CM, Rogers SW, Pabreza LA, Wolfe BB, and Kellar KJ (1992) A subtype of nicotinic cholinergic receptor in rat brain is composed of α4 and β2 subunits and is upregulated by chronic nicotine treatment. Mol Pharmacol 41:31-37.
11. Gao F, Bren N, Burghardt TP, Hansen S, Henchman RH, Taylor P, McCammon JA, and Sine SM (2005) Agonist-mediated conformational changes in acetylcholine-binding protein revealed by simulation and intrinsic tryptophan fluorescence. J Biol Chem 280:8443-8451.
12. Gentry C and Lukas R (2002) Regulation of nicotinic acetylcholine receptor numbers and function by chronic nicotine exposure. Curr Drug Targets CNS Neurol Disord 1:359-385.
13. Gentry C, Wilkins L, and Lukas R (2003) Effects of prolonged nicotinic ligand exposure on function of heterologously expressed human α4β2 and α4β4 nicotinic acetylcholine receptors. J Pharmacol Exp Ther 304:206-216.
14. Gopalakrishnan M, Molinari EJ, and Sullivan JP (1997) Regulation of human α4β2 neuronal nicotinic acetylcholine receptors by cholinergic channel ligands and second messenger pathways. Mol Pharmacol 52:524-534.
15. Jia L, Flotides K, Li M, and Cohen B (2003) Nicotine trapping causes the persistent desensitization of α4β2 nicotinic receptors expressed in oocytes. J Neurochem 84:753-766.
16. Karadsheh MS, Shah MS, Tang X, Macdonald RL, and Stitzel JA (2004) Functional characterization of mouse α4β2 nicotinic acetylcholine receptors stably expressed in HEK293T cells. J Neurochem 98:1138-1150.
17. 2+ permeability, conductance and gating of human α4β2 nicotinic acetylcholine receptors. J Neurosci 17:9035-9047.
18. Kuryatov A, Olale F, Cooper J, Choi C, and Lindstrom J (2000) Human α6 AChR subtypes: subunit composition, assembly and pharmacological responses. Neuropharmacology 39:2570-2590.
19. Lindstrom JM (2000) The structure of neuronal nicotinic receptors, in Neuronal Nicotinic Receptors (Clementi F, Gotti C, and Fornasari D eds) vol 144, pp 101-162, Springer-Verlag, New York.
20. Maskos U, Molles BE, Pons S, Besson M, Guiard BP, Guilloux JP, Evrard A, Cazala P, Cormier A, Mameli-Engvall M, et al. (2005) Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors. Nature (Lond) 436:103-107.
21. Meyer E, Xiao Y, and Kellar K (2001) Agonist regulation of rat α3β4 nicotinic acetylcholine receptors stably expressed in human embryonic kidney 293 cells. Mol Pharmacol 60:568-576.
22. Morello J-P, Salahpour A, Laperriere A, Vernier V, Arthus M-F, Lonergan M, Petaja-Repo U, Angers S, Marin D, Bichet D, et al. (2000) Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants. J Clin Investig 105:887-895.
23. Nelson ME, Kuryatov A, Choi CH, Zhou Y, and Lindstrom JM (2003) Alternate stoichiometries of α4β2 nicotinic acetylcholine receptors. Mol Pharmacol 63:332-341.
24. Olale F, Gerzanich V, Kuryatov A, Wang F, and Lindstrom J (1997) Chronic nicotine exposure differentially affects the function of human α3, α4 and α7 neuronal nicotinic receptor subtypes. J Pharmacol Exp Ther 283:675-683.
25. Pacheco MA, Pastoor TE, Lukas RJ, and Wecker L (2001) Characterization of human α4β2 neuronal nicotinic receptors stably expressed in SH-EP1 cells. Neurochem Res 26:683-693.
26. Paradiso K, Zhang J, and Steinbach JN (2001) The C terminus of the human nicotinic α4β2 receptor forms a binding site required for potentiation by an estrogenic steroid. J Neurosci 21:6561-6568.
27. Peng X, Anand R, Whiting P, and Lindstrom J (1994) Nicotine-induced upregulation of neuronal nicotinic receptors results from a decrease in the rate of turnover. Mol Pharmacol 46:523-530.
28. Perry D, Davila-Garcia M, Stockmeier C, and Kellar K (1999) Increased nicotinic receptors in brains from smokers: membrane binding and autoradiography studies. J Pharmacol Exp Ther 289:1545-1552.
29. Petaja-Repo V, Hogue M, Bhalla S, Laperriere A, Morello J-P, and Voucier M (2002) Ligands act as pharmacological chaperones and increase the efficiency of δ opioid receptor maturation. EMBO (Eur Mol Biol Organ) J 21:1628-1637.
30. Ren X-Q, Cheng S-B, Treuil MW, Mukherjee J, Rao J, Braunewell KH, Lindstrom JM, and Anand R (2005) Structural determinants of α4β2 nicotinic acetylcholine receptor trafficking. J Neurosci 25:6676-6686.
31. Sallette J, Bohler S, Benoit P, Soudant M, Pons S, Novere N, Changeux J-P, and Corringer P (2004) An extracellular protein microdomain controls upregulation of neuronal nicotinic acetylcholine receptors by nicotine. J Biol Chem 279:18767-18775.
32. Sallette J, Pons S, Devillers-Thiery A, Soudant M, Carvalho LP, Changeux JP, and Corringer PJ (2005) Nicotine upregulates its own receptors through enhanced intracellular maturation. Neuron 46:595-607.
33. Samochocki M, Hoffle A, Feherenbacher A, Jostoc R, Ludwig J, Christner C, Radia M, Zerlin M, Ulliner C, Pereira E, et al. (2003) Galantamine is an allosteric potentiating ligand of neuronal nicotinic but not muscarinic acetylcholine receptors. J Pharmacol Exp Ther 305:1024-1036.
34. Steinlein O (2004) Genetic mechanisms that underlie epilepsy. Nat Rev Neurosci 5:400-408.
35. Tapper AR, McKinney SL, Nashmi R, Schwarz J, Deshpande P, Labarca C, Whiteaker P, Marks MJ, Collins AC, and Lester HA (2004) Nicotine activation of α4* receptors: sufficient for reward, tolerance and sensitization. Science (Wash DC) 306:1029-1032.
36. Vallejo YF, Buisson B, Bertrand D, and Green WN (2005) Chronic nicotine exposure upregulates nicotinic receptors by a novel mechanism. J Neurosci 25:5563-5572.
37. Wang F, Gerzanich V, Wells GB, Anand R, Peng X, Keyser K, and Lindstrom J (1996) Assembly of human neuronal nicotinic receptor α5 subunits with α3, β2 and β4 subunits. J Biol Chem 271:17656-17665.
38. Wang F, Nelson M, Kuryatov A, Keyser K, and Lindstrom J (1998) Chronic nicotine treatment upregulates human α3β2 but not α3β4 AChRs stably transfected in human embryonic kidney cells. J Biol Chem 273:28721-28732.
39. Whiteaker P, Sharples C, and Wonnacott S (1998) Agonist-induced upregulation of α4β2 nicotinic acetylcholine receptors in M10 cells: pharmacological and spatial definition. Mol Pharmacol 53:950-962.
40. Xiao Y and Kellar KJ (2004) The comparative pharmacology and up-regulation of rat neuronal nicotinic receptor subtype binding sites stably expressed in transfected mammalian cells. J Pharmacol Exp Ther 310:98-107.
41. Zhou Y, Nelson M, Kuryatov A, Choi C, Cooper J, and Lindstrom J (2003) Human α4β2 AChRs formed from linked subunits. J Neurosci 23:9004-9015.